Protalix BioTherapeutics Inc (PLX) Actualités

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Current Report Filing (8-k)

0001006281false00010062812023-05-302023-05-30​​UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C...

Proxy Statement (definitive) (def 14a)

​ UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549...

Current Report Filing (8-k)

0001006281false00010062812023-05-182023-05-18​​UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C...

Current Report Filing (8-k)

0001006281false00010062812023-05-052023-05-05​​UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C...

Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)

      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE...

Amended Annual Report (10-k/a)

0001006281--12-312022FYfalse00010062812022-06-3000010062812023-04-3000010062812022-01-012022-12-31xbrli:sharesiso4217:USDTable of...

Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)

  Prospectus Supplement Filed Pursuant to Rule 424(b)(5) (to Prospectus dated April 29, 2022) Registration No...

Current Report Filing (8-k)

0001006281false00010062812023-02-272023-02-27​​UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C...

Annual Report (10-k)

0001006281--12-312022FYfalse0001006281us-gaap:PrivatePlacementMember2021-06-072021-06-070001006281us-gaap:OverAl...

Current Report Filing (8-k)

0001006281false00010062812023-02-272023-02-27​​UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C...

Current Report Filing (8-k)

0001006281false00010062812023-02-242023-02-24​​UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C...

Amended Statement of Ownership (sc 13g/a)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13G/A Under the Securities...

Current Report Filing (8-k)

0001006281false00010062812022-12-212022-12-21​​UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C...

Quarterly Report (10-q)

0.240.480.070.09475827334376176949498105455566470001006281--12-312022Q3falseP10YP10YP10Y0001006281srt:ChiefFinan...